Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tcm cells and hormonal therapy in advanced prostate cancer
NCT03587285Phase 2Unknown
- Sponsor
- Guangzhou University of Chinese Medicine
- Start
- Sep 2018
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Phase 2, open-label trial in prostate cancer (PCa) (2 cohorts), sponsored by Guangzhou University of Chinese Medicine. Primary endpoint: Incidences of adverse events or serious adverse events at 2 years. Status: unknown.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03587285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03587285.